Blumberg, Y.; Edelstein, M.; Abu Jabal, K.; Golan, R.; Tuvia, N.; Perets, Y.; Saad, M.; Levinas, T.; Saleem, D.; Israeli, Z.;
et al. Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection: A Cross-Sectional Study Israel. J. Clin. Med. 2022, 11, 4420.
https://doi.org/10.3390/jcm11154420
AMA Style
Blumberg Y, Edelstein M, Abu Jabal K, Golan R, Tuvia N, Perets Y, Saad M, Levinas T, Saleem D, Israeli Z,
et al. Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection: A Cross-Sectional Study Israel. Journal of Clinical Medicine. 2022; 11(15):4420.
https://doi.org/10.3390/jcm11154420
Chicago/Turabian Style
Blumberg, Yair, Michael Edelstein, Kamal Abu Jabal, Ron Golan, Neta Tuvia, Yuval Perets, Musa Saad, Tatyana Levinas, Dabbah Saleem, Zeev Israeli,
and et al. 2022. "Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection: A Cross-Sectional Study Israel" Journal of Clinical Medicine 11, no. 15: 4420.
https://doi.org/10.3390/jcm11154420
APA Style
Blumberg, Y., Edelstein, M., Abu Jabal, K., Golan, R., Tuvia, N., Perets, Y., Saad, M., Levinas, T., Saleem, D., Israeli, Z., Alaa, A. R., Elbaz Greener, G., Amital, A., & Halabi, M.
(2022). Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection: A Cross-Sectional Study Israel. Journal of Clinical Medicine, 11(15), 4420.
https://doi.org/10.3390/jcm11154420
